Munehiro Matsushima
Kyoto University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Munehiro Matsushima.
Blood Purification | 1994
Masatomo Yashiro; Eri Muso; Munehiro Matsushima; Ryoichi Nagura; Kenji Sawanishi; Shigetake Sasayama
Cholesterol kinetics in the time course after LDL apheresis using a dextran sulfate cellulose column was analyzed by adapting a two-compartment cholesterol kinetic model. Fifteen sets of serial serum cholesterol concentrations after LDL apheresis from 4 patients with drug-resistant nephrotic hypercholesterolemia due to focal glomerulosclerosis (FGS) were analyzed and cholesterol kinetic parameters were estimated with the nonlinear least-squares method. The fractional cholesterol catabolic rates (Kc; 0.171 +/- 0.073/day, mean +/- SD) were markedly decreased as reported in familial hypercholesterolemia (homo: 0.101/day, hetero: 0.280/day). Cholesterol generation rates (G; 68.0 +/- 28.7 mg/dl/day, mean +/- SD) considerably overlapped the normal range (39.2-77.5 mg/dl/day). This result was compatible with an earlier report that Kc was reduced earlier than G in nephrotic hypercholesterolemia. The time average serum cholesterol concentrations (TAC) in the rebound phase after LDL apheresis can be simulated using these kinetic parameters by the Runge-Kutta-Gill method. According to our previous report, TAC must be reduced to under a near-normal level in order to obtain a beneficial effect on nephrotic syndrome due to FGS. In 10 sets out of the 15, once-weekly treatment of LDL apheresis was sufficient to achieve this aim, but in the remaining 5 cases, more frequent LDL apheresis up to twice a week was necessary in the early phase of treatment. In conclusion, the two-compartment cholesterol kinetic model is useful in clarifying the abnormal cholesterol kinetics in nephrotic syndrome and may be helpful in establishing a more rational strategy of LDL apheresis for nephrotic hypercholesterolemia.
Nephrology Dialysis Transplantation | 1994
Eri Muso; Masatomo Yashiro; Munehiro Matsushima; Haruyoshi Yoshida; Kenji Sawanishi; Shigetake Sasayama
Artificial Organs | 2008
Taisuke Morimoto; Munehiro Matsushima; Nobumasa Sowa; Koki Ide; Kenji Sawanishi
Journal of Japanese Society for Dialysis Therapy | 1992
Masatomo Yashiro; Eri Muso; Munehiro Matsushima; Ryouichi Nagura; Kenji Sawanishi
Japanese Journal of Nephrology | 1991
Masatomo Yashiro; Eri Muso; Haruyoshi Yoshida; Toshihide Shimada; Munehiro Matsushima; Kenji Sawanishi; Taketoshi Sugiyama; Chuichi Kawai
Nihon Toseki Igakkai Zasshi | 1998
Kojiro Makibayashi; Hiroko Tsuji; Seiji Ohashi; Toshio Doi; Eri Muso; Shigetake Sasayama; Munehiro Matsushima; Michihiko Uchida; Kazuro Kanatsu
Nihon Toseki Igakkai Zasshi | 1995
Shinji Nakayama; Hiroyuki Matsushima; Munehiro Matsushima; Ryoichi Nakura; Takaomi Sohma; Masaki Aota; Toshihiko Ban; Kenji Sawanishi
Blood Purification | 1994
John K. Leypoldt; Kim M. Blindauer; Leah J. Langsdorf; Andrew L. Zydney; M.J.F.M. Janssen; P.C. Huijgens; A.A. Bouman; P. L. Oe; J. van der Meulen; Masatomo Yashiro; Eri Muso; Munehiro Matsushima; Ryoichi Nagura; Kenji Sawanishi; Shigetake Sasayama
Blood Purification | 1994
John K. Leypoldt; Kim M. Blindauer; Leah J. Langsdorf; Andrew L. Zydney; M.J.F.M. Janssen; P.C. Huijgens; A.A. Bouman; P. L. Oe; J. van der Meulen; Masatomo Yashiro; Eri Muso; Munehiro Matsushima; Ryoichi Nagura; Kenji Sawanishi; Shigetake Sasayama
Blood Purification | 1994
John K. Leypoldt; Kim M. Blindauer; Leah J. Langsdorf; Andrew L. Zydney; M.J.F.M. Janssen; P.C. Huijgens; A.A. Bouman; P. L. Oe; J. van der Meulen; Masatomo Yashiro; Eri Muso; Munehiro Matsushima; Ryoichi Nagura; Kenji Sawanishi; Shigetake Sasayama